PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds bortezomib to be promising treatment for rheumatoid arthritis

Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models

2010-11-04
(Press-News.org) A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

RA is a chronic, systemic, autoimmune disease characterized by inflammation and joint destruction. The newer biologics, such as the tumor necrosis factor (TNF) inhibitors and monoclonal antibodies, have increased the therapeutic options for patients with RA. However, studies have shown that more than 50% of patients treated with a TNF inhibitor do not meet the ACR 50 improvement criteria—a standard set of measures developed by the college to determine efficacy of drugs in clinical trials.

"The definitive role of biologic agents in treating this difficult-to-cure population has yet to be defined in prospective trials comparing the available therapeutic options," explained study leader Evangelia Yannaki, M.D., of George Papanicolaou Hospital in Thessaloniki, Greece. "Given the lack of options for poor responders and the increased risk of infections and malignancies with available biologic agents for RA, there is a great need for novel therapies that are safe and effective."

The research team explored bortezomib as an optimal treatment for RA because the drug targets multiple pathways. In RA, the most important proinflammatory mediators are regulated by the transcription factor NF-KB—proteins that control genes involved in inflammation and the immune response to infection. Where bortezomib inhibits NF-KB, researchers speculate that the drug may improve autoimmune conditions, such as RA, which are characterized by chronic inflammation.

The analysis demonstrated that in vitro, bortezomib significantly reduced proliferation and increased death of the inflammatory cells in rats with adjuvant induced arthritis (AIA), thereby reducing invasiveness of fibroblast-like cells that are responsible for the damage to the lining of the joints; it also modified the pattern of protein cell signaling (cytokine secretion) in T-lymphocytes that are involved in the immune system response. In vivo, bortezomib significantly improved clinical manifestations of arthritis in these animals, even when administered during the advanced disease phase. Researchers noted that joints in animals treated with the drug displayed limited damage and inflammation, and an obvious bone healing effect was observed.

"Our research showed that bortezomib is a useful treatment in targeting critical cell populations involved in the development of inflammation and autoimmunity in RA," concluded Dr. Yannaki. "We believe that bortezomib should be further explored in a clinical setting, as it represents an attractive intervention for inflammatory conditions and a highly promising agent in the treatment of RA."

INFORMATION: Article: "The Proteasome Inhibitor Bortezomib Drastically Affects Inflammation and Bone Disease in a Rat Model of Adjuvant-Induced Arthritis." Evangelia Yannaki, Anastasia Papadopoulou, Evangelia Athanasiou, Panayotis Kaloyannidis, Argyro Paraskeva, Dimitris Bougiouklis, Panayotis Palladas, Minas Yiangou, and Achilles Anagnostopoulos. Arthritis & Rheumatism; Published Online: October 29, 2010 (DOI: 10.1002/art.27690); Print Issue Date: November 2010. http://onlinelibrary.wiley.com/doi/10.1002/art.27690/abstract

This study is published in the November issue of Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.

About the Journal

Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology (www.rheumatology.org) is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.

About Wiley-Blackwell

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

Media Advisory

ACR Annual Meeting Press Registration Now Open

Press registration is now open to journalists planning to attend the 2010 ACR/ARHP Annual Scientific Meeting in Atlanta. Held November 6-11 at the Georgia World Congress Center, the ACR/ARHP Annual Scientific Meeting is the premier meeting in rheumatology.

For more information, including to view the press conference schedule, visit www.rheumatology.org/education. Follow the meeting on twitter by using the official hashtag: #ACR2010.



ELSE PRESS RELEASES FROM THIS DATE:

Honey bees: Genetic labeling decides about blue blood

2010-11-04
It is hard to believe that they belong to the same species: The large, long-lived queen bee is busy producing offspring throughout her lifetime. The much smaller worker bees, on the other hand, gather food, take care of the beehive, look after and feed the brood – but they are infertile. "The honey bee is an extreme example of different larval development," Professor Frank Lyko explains. Lyko, a scientist at DKFZ, studies how genes are regulated by chemical labeling with methyl groups. This type of regulation is part of what are called epigenetic regulation mechanisms ...

A sweet discovery raises hope for treating Ebola, Lassa, Marburg and other fast-acting viruses

2010-11-04
When a team of European researchers sought to discover how a class of antiviral drugs worked, they looked in an unlikely place: the sugar dish. A new research report appearing in the Journal of Leukocyte Biology (http://www.jleukbio.org) suggests that a purified and modified form of a simple sugar chain may stop fast-acting and deadly viruses, such as Ebola, Lassa, or Marburg viruses, in their tracks. This compound, called chlorite-oxidized oxyamylose or COAM, could be a very attractive therapeutic option because not only did this compound enhance the early-stage immune ...

Language appears to shape our implicit preferences

2010-11-04
CAMBRIDGE, Mass., Nov. 3, 2010 -- The language we speak may influence not only our thoughts, but our implicit preferences as well. That's the finding of a study by psychologists at Harvard University, who found that bilingual individuals' opinions of different ethnic groups were affected by the language in which they took a test examining their biases and predilections. The paper appears in the Journal of Experimental Social Psychology. "Charlemagne is reputed to have said that to speak another language is to possess another soul," says co-author Oludamini Ogunnaike, ...

Researchers expand cyberspace to fight chronic condition in breast cancer survivors

Researchers expand cyberspace to fight chronic condition in breast cancer survivors
2010-11-04
COLUMBIA, Mo. – Lymphedema is a chronic condition that causes swelling of the limbs and affects physical, mental and social health. It commonly occurs in breast cancer survivors and is the second-most dreaded effect of treatment, after cancer recurrence. Every day, researchers throughout the world learn more about the condition and how it can be treated. Now, University of Missouri researchers are developing a place in cyberspace where relevant and timely information can be easily stored, searched, and reviewed from anywhere with the goal of improving health care through ...

Earth's climate change 20,000 years ago reversed the circulation of the Atlantic Ocean

2010-11-04
The Atlantic Ocean circulation (termed meridional overturning circulation, MOC) is an important component of the climate system. Warm currents, such as the Gulf Stream, transport energy from the tropics to the subpolar North Atlantic and influence regional weather and climate patterns. Once they arrive in the North the currents cool, their waters sink and with them they transfer carbon from the atmosphere to the abyss. These processes are important for climate but the way the Atlantic MOC responds to climate change is not well known yet. An international team of investigators ...

Psyllid identification key to area-wide control of citrus greening spread

2010-11-04
At least six psyllid species have been found in the citrus-growing areas of the Rio Grande Valley of Texas, according to a U.S. Department of Agriculture (USDA) scientist who is working to control the spread of the psyllid-transmitted citrus greening disease. A few years ago, citrus growers in south Texas noticed a new insect, the Asian citrus psyllid, on their citrus trees. This was a cause for concern, because this tiny pest is responsible for transmitting citrus greening, also known as Huanglongbing (HLB). The disease was first detected in Florida in 2005 and now ...

Main squeeze not needed for boa mom

Main squeeze not needed for boa mom
2010-11-04
In a finding that upends decades of scientific theory on reptile reproduction, researchers at North Carolina State University have discovered that female boa constrictors can squeeze out babies without mating. More strikingly, the finding shows that the babies produced from this asexual reproduction have attributes previously believed to be impossible. Large litters of all-female babies produced by the "super mom" boa constrictor show absolutely no male influence – no genetic fingerprint that a male was involved in the reproductive process. All the female babies ...

UGA study finds moving animals not a panacea for habitat loss

UGA study finds moving animals not a panacea for habitat loss
2010-11-04
Athens, Ga. – New University of Georgia research suggests moving threatened animals to protected habitats may not always be an effective conservation technique if the breeding patterns of the species are influenced by a social hierarchy. Research, published in the early online edition of the journal Biological Conservation, found an initial group of gopher tortoises released on St. Catherine's Island, Ga. were three times more likely to produce offspring than a later-introduced group, although the initial group had a much smaller proportion of reproduction-aged males. "There ...

Most river flows across the US are altered by land and water management

2010-11-04
The amount of water flowing in streams and rivers has been significantly altered in nearly 90 percent of waters that were assessed in a new nationwide USGS study. Flow alterations are a primary contributor to degraded river ecosystems and loss of native species. "This USGS assessment provides the most geographically extensive analysis to date of stream flow alteration," said Bill Werkheiser, USGS Associate Director for Water. "Findings show the pervasiveness of stream flow alteration resulting from land and water management, the significant impact of altered stream ...

The developmental dynamics of the maize leaf transcriptome

2010-11-04
Photosynthesis is arguably the most impressive feat of nature, where plants harvest light energy and convert it into the building blocks of life at fantastically high efficiency. Indeed modern civilization became possible only with the cultivation of plants for food, shelter and clothing. While scientists have been able to discover details of the fascinating process by which plants store solar energy as chemical energy, how developing plants build and regulate their solar reactors is still poorly understood. How many genes are involved, and which are the most important? ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Study finds bortezomib to be promising treatment for rheumatoid arthritis
Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models